>
Trump envoys Witkoff, Kushner to meet Putin in Moscow as US pushes new Ukraine talks
Davos 2026 Live Updates: Trump says he won't use force to take Greenland, warns Europe...
Teacher Enoch Burke Arrested Again at Wilson's Hospital School...
Ray Dalio: "The USD may lose its reserve currency status."
The day of the tactical laser weapon arrives
'ELITE': The Palantir App ICE Uses to Find Neighborhoods to Raid
Solar Just Took a Huge Leap Forward!- CallSun 215 Anti Shade Panel
XAI Grok 4.20 and OpenAI GPT 5.2 Are Solving Significant Previously Unsolved Math Proofs
Watch: World's fastest drone hits 408 mph to reclaim speed record
Ukrainian robot soldier holds off Russian forces by itself in six-week battle
NASA announces strongest evidence yet for ancient life on Mars
Caltech has successfully demonstrated wireless energy transfer...
The TZLA Plasma Files: The Secret Health Sovereignty Tech That Uncle Trump And The CIA Tried To Bury

Now, researchers have developed a tiny, rotini-shaped spiral that could one day be deployed in the thousands for targeted drug delivery.
Current treatments for eye diseases such as glaucoma or diabetic macular edema are delivered through direct injection or eyedrops. Those methods are effective but imprecise, often blanketing the entire eye in medication.
So scientists used nanoscale 3D printing to create spiral-shaped robots small enough to pass through the dense jelly known as the vitreous humor that makes up most of the eyeball. The researchers added a slippery coating and magnetic materials so they could propel the microbots through the eye using a magnetic field.
The scientists then collected pig eyes from a slaughterhouse, injected a solution containing about 10,000 bots into each eye, and then placed them in a magnetic field, which they used to propel the bots to the retina at the back of the eye. Imaging showed the swarm successfully reached the retina in less than 30 minutes, about 10 times faster than letting similar-size particles diffuse through the eye, the researchers reported last week in Science Advances.